NEXIEN BIOPHARMA, INC. financial data

Location
Glendale, CO
Fiscal year end
30 June
Latest financial report
10-Q - Q1 2025 - 14 May 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.14 % -82.4%
Debt-to-equity -101 % +5.4%
Return On Equity 46.26 % -44.5%
Return On Assets -4,017 % -2.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 70,772,196 shares +4.9%
Common Stock, Shares, Outstanding 70,772,196 shares +4.9%
Entity Public Float 686,961 USD -56.9%
Common Stock, Value, Issued 7,077 USD +4.9%
Weighted Average Number of Shares Outstanding, Basic 70,772,196 shares +6.6%
Weighted Average Number of Shares Outstanding, Diluted 70,772,196 shares +6.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 0 USD
General and Administrative Expense 74,617 USD -39.8%
Net Income (Loss) Attributable to Parent -188,082 USD +23.6%
Earnings Per Share, Basic 0 USD/shares 0%
Earnings Per Share, Diluted 0 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8,285 USD -17.7%
Assets, Current 8,285 USD -41.9%
Assets 8,285 USD -41.9%
Liabilities, Current 458,801 USD +35.1%
Liabilities 458,801 USD +35.1%
Retained Earnings (Accumulated Deficit) -11,636,041 USD -1.6%
Stockholders' Equity Attributable to Parent -450,516 USD -38.5%
Liabilities and Equity 8,285 USD -41.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9,230 USD +46%
Net Cash Provided by (Used in) Financing Activities 10,000 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 70,772,196 shares +4.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 770 USD
Deferred Tax Assets, Valuation Allowance 726,195 USD +5.4%
Deferred Tax Assets, Operating Loss Carryforwards 726,195 USD +5.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital 11,178,448 USD +0.56%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%